#BREAKINGNEWS: We have reached two milestones with the submission of our first ever BLA for our investigational oncolytic immunotherapy RP1 and designation as a Breakthrough Therapy from the FDA. Read more here: https://lnkd.in/dDRmHk_j
关于我们
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
- 网站
-
https://www.replimune.com
Replimune的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Woburn，MA
- 类型
- 上市公司
- 创立
- 2015
地点
-
主要
获取路线
US，MA，Woburn，01801
Replimune员工
动态
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Today at #SITC24 we presented data, including initial biomarker analyses, from the IGNYTE clinical trial of our investigational oncolytic immunotherapy RP1 combined with nivolumab in anti-PD1 failed melanoma. Learn more about our late-breaking oral presentation here: https://lnkd.in/esE785kY
-
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
We were honored to support the Melanoma Research Foundation at their 23rd Annual New York City Gala. It was an inspirational evening celebrating the hard work of the Melanoma Research Foundation and the honorees who work tirelessly to drive innovation and progress in the fight against melanoma. #MRFNYCGala24
-
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.